Product Development

CMC Process Development and Optimization

Advancing your biologics development

Alira Health CMC Team helps develop technical design for biotherapeutic production and optimize manufacturing processes.

We also provide additional support for small molecule therapeutics at every stage of production:
  • Antibody engineering and developability
  • Cell line development
  • Upstream development
  • Downstream development
  • Formulation development
  • Product and process characterization

Why choose Alira Health?

Alira Health is your partner in every stage of production, working closely with you to design, optimize and deliver advanced biologics. Our subject matter experts will:

  • Advise and support process development activities including antibody engineering and developability, creation of a highly productive cell line, upstream, downstream, and formulation development
  • Actively engage in planning for scale up and cGMP manufacture of drug substance and product, analytical method development and QC
  • Provide large molecule therapeutic development expertise including microbial, mammalian, and yeast cell expression systems
  • Leverage extensive experience with monoclonal antibodies and derivatives, including bispecifics, fusion proteins, and antibody drug conjugates
  • Deliver technical expertise and support for small molecule therapeutic development

Related news

Advanced Analytics Digital Health Pharma Research & Development
Publications December 10, 2021
Leveraging Data Intelligence for Effective Opportunity Screening and Prioritization in Drug Discovery
Our biotech client needed an innovative, effective way to identify which binding sites and therapeutic indications they should target for the development of new therapeutic agents for(...)
Research & Development
Events November 24, 2021
Event: Innovations In Wound Healing Annual Conference
Join Dr. Mitch Sanders for an exclusive poster session at this event.
Research & Development
Events October 20, 2021
Event: SAWC Fall 2021
Join Dr. Sanders at SAWC Fall in Las Vegas, NV.
Due Diligence Research & Development
Publications August 18, 2021
Infographic: Indication Prioritization and Pre-Commercial Value Assessment
Download our infographic on Indication Prioritization and Pre-Commercial Value Assessment.
Pharma Research & Development
Publications August 2, 2021
Infographic: Prioritization Strategy of R&D Targets for Biotech Company
Download our infographic on Prioritization Strategy of R&D Targets for Biotech Company
Research & Development
Publications June 9, 2021
EU Supply Integrity Guidelines
Check out Alira Health's latest publication, “EU Supply Integrity Guidelines”. In the document, best practices for European distribution and supply integrity management are highlighted(...)
Research & Development
Publications May 27, 2021
Buffers – Navigating New Demands On Downstream Raw Materials
The COVID-19 pandemic has put unusual pressures on the supply and demand of raw materials required for the production and purification of biologics. A specific concern for the biomanufacturing(...)
Welcome to Alira Health. This site is best viewed in Chrome, Microsoft Edge, or Firefox.